TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive New Cancer Control Projects Aimed At Upgrading Care At Community Level; 56 Contracts Anticipated November 15, 1974